24-hour noninvasive ambulatory blood pressure monitoring has greater prognostic significance in determining risk for target-organ damage compared with office blood pressure measurements.
Does 24-hour ambulatory blood pressure monitoring improve cardiovascular risk stratification compared to office blood pressure measurements in patients with hypertension?
24-hour ambulatory blood pressure monitoring offers superior prognostic value for assessing target-organ damage risk compared to standard office blood pressure measurements.
During the last 25 years, 24-hour noninvasive ambulatory blood pressure monitoring (ABPM) has evolved from a research tool of limited clinical use into an important tool for stratifying cardiovascular risk and guiding therapeutic decisions. Until recently, clinical use of ABPM focused on identifying patients with white-coat hypertension, but accumulated evidence now points to greater prognostic significance of ABPM in determining risk for target-organ damage compared with that of office blood pressure measurements. Clinicians involved in the care of patients with hypertension should familiarize themselves with the role of this technology and how to use it in an appropriate and cost-effective manner.
Ernst et al. (Wed,) conducted a review in Hypertension. 24-hour noninvasive ambulatory blood pressure monitoring (ABPM) vs. Office blood pressure measurements was evaluated. 24-hour noninvasive ambulatory blood pressure monitoring has greater prognostic significance in determining risk for target-organ damage compared with office blood pressure measurements.